世界の骨粗しょう症治療・予防市場予測:抗嘔吐薬、骨粗しょう症治療薬、再吸収阻害薬、同化薬...市場調査レポートについてご紹介

【英文タイトル】Osteoporosis Treatment and Prevention: World Drug Market Forecast 2014-2024 & Future Prospects for Leading Companies

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Executive Summary
1.1 The Global Osteoporosis Drug Market Review
1.2 The Global Osteoporosis Drug Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2. Introduction to Osteoporosis
2.1 Osteoporosis Prevalence and Incidence, 2014
2.2 Osteoporosis: The Silent Killer
2.3 Osteoblasts are Critical in Bone Healing
2.4 Classifying Osteoporosis by Types
2.5 Classifying Osteoporosis by Treatments
2.5.1 Antiresorptive Medication
2.5.2 Anabolic Medication
2.6 Osteoporosis Risk Factors

3. The Global Osteoporosis Drug Market, 2014-2024
3.1 Scope of this Report
3.2 The Global Osteoporosis Drug Market in 2013
3.3 The Global Osteoporosis Drug Market: Sales Forecast 2014-2024
3.4 Breakdown of the World Osteoporosis Drug Market by Therapeutic Classes, 2013
3.5 The Global Osteoporosis Drug Market by Therapeutic Classes: Sales Forecast 2014-2024
3.6 Breakdown of the World Osteoporosis Drug Market by Leading Drugs, 2013
3.6.1 The Global Osteoporosis Drug Market by Leading Drugs: Sales Forecast 2014-2024
3.7 Which Osteoporosis Drugs Will Lead the Market in 2024?
3.7.1 Osteoporosis Products Pipeline, 2014
3.7.2 Forteo (Teriparatide) -Eli Lilly, 2014
3.7.3 Evista(Raloxifene) – Eli Lilly, 2014
3.7.4 Prolia (Denosumab) – Amgen, GSK and Daiichi Sankyo, 2014
3.7.5 Actonel/Atelvia (Risendronate) -Sanofi, Actavis, Ajinomoto Pharmaceuticals and Eisai, 2014
3.7.6 Fosamax (Alendronate) – Merck, 2014
3.7.7 Reclast/Aclasta (Zoledronic Acid) – Novartis, 2014
3.7.8 Boniva (Ibandronate) –Roche and GSK, 2014
3.7.9 Duavee (Bazedoxifene/Conjugated Estrogens) – Pfizer and Ligand Pharmaceuticals, 2014
3.7.10 Odanacatib (MK 0822) – Merck, 2014
3.7.11 Romosozumab (AMG 785) – Amgen and UCB, 2014
3.7.12 The Global Osteoporosis Drug Market: Drivers and Restraints 2014-2024

4. Leading National Osteoporosis Drug Markets, 2014-2024
4.1 Regional Breakdown of the World Osteoporosis Drug Market, 2013
4.2 Regional Breakdown of the World Osteoporosis Drug Market: Sales Forecast by Region, 2014-2024
4.3 How Will Regional Market Shares Change to 2024?
4.4 The US Osteoporosis Drug Market, 2013
4.4.1 The US Osteoporosis Drug Market: Forecast 2014-2024
4.5 Reimbursement Situation in the US, 2014
4.5.1 The US Keeps Dominating the Osteoporosis Drug Market: What About Healthcare Coverage?
4.6 The US Osteoporosis Drug Market: Drivers and Restraints, 2014-2024
4.7 The Leading European Osteoporosis Drug Markets, 2013
4.7.1 The Leading European Osteoporosis Drug Markets: Forecasts 2014-2024
4.7.2 The German Osteoporosis Drug Market Forecast, 2014-2024
4.7.3 The French Osteoporosis Drug Market Forecast, 2014-2024
4.7.4 The UK Osteoporosis Drug Market Forecast, 2014-2024
4.7.5 The Italian Osteoporosis Drug Market Forecast, 2014-2024
4.7.6 The Spanish Osteoporosis Drug Market Forecast, 2014-2024
4.8 The Japanese Osteoporosis Drug Market, 2013
4.8.1 The Japanese Osteoporosis Drug Market Forecast, 2014-2024
4.8.2 Recent Trends in the Japanese Osteoporosis Drug Market, 2014
4.9 The BRICK Countries Osteoporosis Drug Market, 2013
4.9.1 The BRICK Countries Osteoporosis Drug Market Forecast, 2014-2024
4.9.2 The Chinese Osteoporosis Drug Market Forecast, 2014-2024
4.9.2.1 Main Companies in the Chinese Osteoporosis Drug Market, 2014
4.9.2.2 Growth Drivers in the Chinese Osteoporosis Drug Market, 2014-2024
4.9.3 The Indian Osteoporosis Drug Market Forecast, 2014-2024
4.9.4 The Russian Osteoporosis Drug Market Forecast, 2014-2024
4.9.5 The Brazilian Osteoporosis Drug Market Forecast, 2014-2024
4.9.6 The South Korean Osteoporosis Drug Market Forecast, 2014-2024
4.9.7 The BRICK Countries Osteoporosis Drug Market: Drivers and Restraints, 2014-2024
4.10 The Osteoporosis Drug Market Forecast in the Rest of the World, 2014-2024
4.10.1 Additional Considerations: Challenges for Aging Populations by Region, 2014

5. Global Antiresorptive Drugs Market, 2014-2024
5.1 The Global Antiresorptive Drugs Market Forecast 2014-2024
5.1.1 Breakdown of the Antiresorptive Drugs Market by Drug Category, 2013
5.2 The Global Antiresorptives Drug Market by Drug Category: Sales Forecast 2014-2024
5.3 The Global Bisphosphonates Market, 2013
5.4 The Global Bisphosphonates Drug Market: Sales Forecast 2014-2024
5.5 Breakdown of the Global Bisphosphonates Market: Sales Forecast by Leading Drugs 2014-2024
5.5.1 Actonel/Atelvia (Risedronate)
5.5.1.1 History of Actonel/Atelvia (Risedronate)
5.5.1.2 Generic Competition for Actonel/Atelvia (Risedronate), 2014
5.5.1.3 Actonel/Atelvia (Risedronate) Sales Forecast 2014-2024
5.5.2 Fosamax (Alendronate)
5.5.2.1 History of Fosamax (Alendronate)
5.5.2.2 Generic Competition for Fosamax (Alendronate), 2014
5.5.2.3 Fosamax (Alendronate) Sales Forecast 2014-2024
5.5.3 Reclast/Aclasta (Zoledronic Acid)
5.5.3.1 Reclast/Aclasta (Zoledronic Acid) Strengths and Weaknesses, 2014
5.5.3.2 Reclast/Aclasta (Zoledronic Acid) in the Leading Regional Markets, 2014
5.5.3.3 Generic Competition for Reclast/Aclasta (Zoledronic Acid), 2014
5.5.3.4 Reclast/Aclasta (Zoledronic Acid) Sales Forecast 2014-2024
5.5.4 Boniva (Ibandronate)
5.5.4.1 Boniva (Ibandronate): Sales Forecast 2014-2024
5.6 The Global SERMs Drug Market: Sales Forecast 2014-2024
5.7 Breakdown of the Global SERMs Market: Sales Forecast by Leading Drugs 2014-2024
5.7.1 Evista (Raloxifene)
5.7.1.1 Generic Competition for Evista (Raloxifene), 2014
5.7.1.2 Evista (Raloxifene) Sales Forecast 2014-2024
5.7.2 Duavee/Aprela (Bazedoxifene and Conjugated Estrogens)
5.7.2.1 Duavee/Aprela (Bazedoxifene and Conjugated Estrogens) in the Leading Regional Markets, 2014
5.7.2.2 History of Duavee/Aprela (Bazedoxifene and Conjugated Estrogens)
5.7.2.3 Duavee/Aprela (Bazedoxifene and Conjugated Estrogens) Sales Forecast 2014-2024
5.8 The Global RANKL Antibody Market: Sales Forecast 2014-2024
5.8.1 Prolia (Denosumab)
5.8.1.1 History of Prolia (Denosumab)
5.8.1.2 Prolia to Drive the Market in 2017
5.8.1.3 Safety Profile
5.8.1.4 Prolia: Patent Expiries
5.8.1.5 Prolia (Denosumab) Sales Forecast 2014-2024
5.9 The Global Cathepsin K Inhibitors Market: Sales Forecast 2014-2024
5.9.1 Odanacatib
5.9.1.1 Odanacatib Sales Forecast 2014-2024
5.10 Other Antiresorptive Drugs, 2014
5.10.1 Protelos
5.10.2 Calcitonin-Salmon
5.10.3 Binosto
5.11 Drivers and Restraints for the Global Antiresorptives Drug Market, 2014-2024

6. The Global Anabolic Drugs Market, 2014-2024
6.1 The Global Anabolic Drugs Market, 2013
6.2 The Global Anabolics Drug Market by Drug Category: Sales Forecast 2014-2024
6.3 The Human Recombinant Parathyroid Hormone Peptides Market, 2014
6.3.1 Forteo (Teriparatide) Market: Sales Forecast 2014-2024
6.3.1.1 Forteo Offers a Differentiating Factor in 2014
6.4 The Anti-Sclerostin Market, 2014
6.4.1 Romosozumab: Sales Forecast 2014-2024
6.5 Other Anabolic Drugs
6.5.1 Blosozumab (LY2541546): Second in Class Sclerostin Antibody
6.5.2 ZP-PTH: Parathyroid by Way Micro Needle Patch
6.5.3 ZT-034: Will Need More Than Biomarkers for Approval
6.5.4 Preotact/Preos: Will it be Introduced in the Market Again?
6.5.5 BA-058 (Abaloparatide): Potential Competitor for Forteo
6.5.6 PTH(1-31)NH2: Future Dual-Action Drug

7. Leading Companies in the Osteoporosis Drug Market, 2014
7.1 Leading Companies in the Osteoporosis Drug Market, 2013
7.2 Expected Company Leaders in the OsteoporosisDrug Market in 2024
7.3 Eli Lilly and Co
7.3.1 Eli Lilly Osteoporosis Drug Sales Forecast, 2014-2024
7.4 Amgen
7.4.1 Amgen’s Osteoporosis Product Portfolio
7.4.2 Amgen Osteoporosis Drug Sales Forecast, 2014-2024
7.5 UCB
7.5.1 UCB Osteoporosis Drug Sales Forecast, 2014-2024
7.6 GSK
7.6.1 GSK Osteoporosis Drug Sales Forecast, 2014-2024
7.7 Merck
7.7.1 Merck Osteoporosis Drug Sales Forecast, 2014-2024
7.8 Actavis
7.9 Sanofi
7.10 Pfizer
7.11 Novartis

8. Qualitative Analysis of the Global Osteoporosis Drug Market, 2014-2024
8.1 Pestel Analysis
8.1.1 Political Factors
8.1.2 Economic Factors
8.1.3 Socio-Cultural Factors
8.1.4 Technological Factors
8.1.5 Environmental Factors
8.1.6 Legal Factors
8.2 Porter’s Five Forces Analysis of the Osteoporosis Drugs Market
8.2.1 Competitive Rivalry: High Rivalry Among Competitors
8.2.1.1 Eli Lilly and Amgen Dominate the Biological Osteoporosis Drug Market
8.2.2 Potential Entrants into the Osteoporosis Drug Market: Low Threat of New Entrants
8.2.3 Medium Threat of Substitutes: Who Are The Latent Substitutes?
8.2.4 High Power of Suppliers: Drug Manufacturers Still Have the Power to Lead the Market
8.2.5 High Power of Buyers: Big Pharma to Engulf Smaller Companies
8.3 SWOT Analysis and Strategies
8.3.1 Strengths: Smart Thinking
8.3.2 Weaknesses: Not An Easy Market
8.3.2.1 Patent Expiries
8.3.3 Opportunities: Changing Social Trends
8.3.4 Threats: Highly Stringent but Necessary Regulations
8.3.4.1 Drug Side-Effect Publicity
8.3.4.2 Reimbursement for Bone Metabolism Drugs
8.4 Challenges to Overcome for the Future Osteoporosis Drug Market

9. Expert Opinions
9.1 Interview with Dr. Karl Grindulis, Consultant Rheumatologist at Sandwell General Hospital, West Bromwich, UK
9.1.1 Calcitonin-Salmon in the UK
9.1.2 Personalised Medicine
9.1.3 Expert Views on Romosozumab
9.1.4 Key Factors for the Future
9.2 Interview with Dr. Matthew Drake, Consultant in the Department of Medicine, Division of Endocrinology, Mayo Clinic Rochester, Minnesota, US
9.2.1 Skeletal Anabolic Agents Remain the Biggest Unmet Need
9.2.2 Calcitonin-Salmon: not Recommendable
9.2.3 Shifting to Generics
9.2.4 Romosozumab: Potential Blockbuster
9.2.5 Odanacatib: Intriguing Future Performance
9.2.6 Focusing on Patients with Rare Skeletal Disorders may Give Some Answers

10. Conclusions
10.1 The World Osteoporosis Drug Market by Therapeutic Classes, 2013
10.2 The World Osteoporosis Drug Market Forecast by Drug Category, 2014-2024
10.3 The Global Osteoporosis Drug Market Forecast by Regional Markets, 2014-2024
10.4 The Global Osteoporosis Drug Market Forecast by Leading Drugs, 2014-2024
10.4.1 Leading Companies for the Osteoporosis Drug Market
10.5 Drivers for the Osteoporosis Drugs Market, 2014-2024


【レポート販売概要】

■ タイトル:世界の骨粗しょう症治療・予防市場予測:抗嘔吐薬、骨粗しょう症治療薬、再吸収阻害薬、同化薬
■ 英文:Osteoporosis Treatment and Prevention: World Drug Market Forecast 2014-2024 & Future Prospects for Leading Companies
■ 発行日:2014年5月
■ 調査会社:visiongain
■ 商品コード:VISG409054
■ 調査対象地域:グローバル
  • Global Planned Oil and Chemicals Storage Industry, 2013 – Investment Opportunities, Analysis and Forecasts of All Planned Terminals to 2017
    Global Planned Oil and Chemicals Storage Industry, 2013 - Investment Opportunities, Analysis and Forecasts of All Planned Terminals to 2017 Summary “Global Planned Oil and Chemicals Storage Industry, 2013 - Investment Opportunities, Analysis and Forecasts of All Planned Terminals to 2017”, is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive informatio …
  • ライナーレスラベルの世界市場2016-2020
    About the Linerless Labels Market Labels are primarily printed pieces of paper, film, polymer, or other materials affixed to a product, or imprinted on the package or the body of a product, which contains important information about the product and company. There are different types of labels available in the market with different features, such as pressure-sensitive, in-mold, and heat-shrink. Oft …
  • 痔疾(Hemorrhoids):世界の治験レビュー(2015年上半期版)
    Hemorrhoids Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Hemorrhoids Global Clinical Trials Review, H1, 2015" provides data on the Hemorrhoids clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemorrhoids. It includes an overview of the trial numbers and their recruitment status as per the site of …
  • 世界の魚・シーフード食品市場動向:ニュース・イベント(2014年5月)
    Synopsis The report provides a review of the latest news and key events in the global fish & seafood market during May 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global fish & seafood market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the …
  • 世界の殺菌空気清浄機市場2015
    The Global Air Sterilization Purifier Industry Report 2015 is a professional and in-depth study on the current state of the Air Sterilization Purifier industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Air Sterilization Purifier market analysis is provided for the international markets including devel …
  • 電子メール暗号化の世界市場2016-2020
    About E-Mail Encryption E-mails are one of the most important modes of communication among employees of any organization. Confidential data of an organization is exchanged through e-mails over different networks. A number of wired and wireless networks are used for data transmission in an organization, and these networks are vulnerable to malware attacks. As e-mails carry an organization's confide …
  • 音声分析の世界市場分析:展開別(ソリューション、サービス)、企業規模別(中小企業、大企業)、エンドユーザー別(BFSI、通信、IT、小売、ヘルスケア、ホスピタリティ)、セグメント予測、2014-2025
    The speech analytics market is expected to reach USD 1.64 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to witness a robust growth exceeding a CAGR of 10% over the forecast period. This growth is ascribed to the increasing emphasis by organizations on improving the market intelligence capabilities along with the growing prominence of voice in the m …
  • 短波赤外検出装置の世界市場
    Short wave IR (SWIR) detectors are transducers that convert radiation of objects in the short wave infrared range to a measurable form. They are cooled detectors that give better performance. MCT technology is mainly used to manufacture short wave IR detectors. This research report categorizes the global SWIR detector market on the basis of material, application, and geography. Various materials u …
  • 産業用保護靴のオーストラリア・ニュージーランド市場:スタンダード別、種類別、用途別
    The ANZ industrial protective footwear market size was valued at $55.0 million in 2018 and is projected to reach $77.2 million by 2026, registering a CAGR of 4.5% from 2019 to 2026. ANZ Industrial protective footwear includes safety footwear used for worker’s safety across different industries such as construction, manufacturing, chemical, pharmaceuticals, oil & gas, food, transportation, and mini …
  • 過酢酸の世界市場2015-2019
    About Peracetic Acid Peroxyacetic acid or peracetic acid (PAA) is a colorless liquid that is formed by the reaction of acetic acid with hydrogen peroxide or by the autoxidation of acetaldehyde. The chemical is commercially sold in its distilled form or as a 1-50% solution containing acetic acid, hydrogen peroxide, and water. Peracetic acid is known to be one of the strongest oxidizing agent with a …
  • 耐摩耗コーティング剤の世界市場予測(~2024年)
    “Stringent regulations on VOC emission are expected to drive the global abrasion resistant coatings market.” The market size for abrasion resistant coatings is projected to grow from USD 8.0 billion in 2019 to USD 11.1 billion by 2024, at a CAGR of 6.5% during the forecast period. The major driving factors for the market are stringent EU and US regulations regarding VOC emission. The other major d …
  • 世界のアウトドア服市場動向
    “Outdoor is a metaphor for freedom, adventure, adrenalin, extraversion, creativity, dynamism, and personal power.” Mike Lipkin, president of Lipkin/Environics Report extract: Outdoor brands have benefitted from the overall casualisation of apparel, while maintaining a “cool” factor based on an implied lifestyle of adventure, leisure, and sport. The pricing of high-end technical apparel makes these …
  • 世界の抗トロンビンIII検査市場
    The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and AT III testing specifically, will become more standardized, offering oppo …
  • 産業用照明の世界市場2017-2021
    About Industrial Lighting The lighting industry includes general lighting, automotive lighting, and backlighting. The general lighting market is the major revenue-generating segment, followed by automotive lighting and backlighting. The general lighting market includes lighting applications for residential, industrial, commercial, outdoor, and architectural purposes. The residential and commercial …
  • 産業用保護服の世界市場の収益分析:製品別(耐久性、使い捨て)、用途別(難燃性衣料品、化学防護服(放射線防護、粒子状物質)、クリーンルーム用衣服、機械保護服、限定汎用服)、セグメント予測
    The global industrial protective clothing market is expected to reach USD 13.30 billion by 2022, according to a new report by Grand View Research, Inc. Rising concern towards worker’s health and safety across a wide host of end-use industries including chemical, oil & gas and manufacturing is expected to remain a key driving factor for global industrial protective clothing market over next seven y …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。